Clal Biotechnology Industries Ltd (CBI) — Cash Flow Quality Index
Clal Biotechnology Industries Ltd (CBI) has a Cash Flow Quality Index of -1.51x as of June 2023. Operating cash flow of ILA-1.82 Million is below net income of ILA1.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CBI cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Clal Biotechnology Industries Ltd Cash Flow Quality Index (2009–2020)
Historical Cash Flow Quality Index for Clal Biotechnology Industries Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CBI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Clal Biotechnology Industries Ltd (2009–2020)
Year-by-year earnings quality comparison for Clal Biotechnology Industries Ltd. For live market cap and the full company financial profile, see Clal Biotechnology Industries Ltd (CBI) total market value.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | -0.30x | ILA-33.23 Million | ILA109.03 Million | ▲ +13.9% |
| 2010 | -0.35x | ILA-111.93 Million | ILA316.19 Million | ▲ +79.4% |
| 2009 | -1.72x | ILA-86.86 Million | ILA50.55 Million | — |